Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women (OvAR-Y): an In-Silico Feasibility Trial

NCT06904365 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06904365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06904365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women (OvAR-Y): an In-Silico Feasibility Trial
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
April 8, 2025
Completion date
October 31, 2026
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, bladder cancer, breast cancer, cervix cancer, colon cancer, gastric cancer, head and neck cancer, liver cancer, lung cancer, rectal cancer, sarcoma, uterine cancer